Connect with us

Basic Materials

Neogen Chemicals Limited (NSE: NEOGEN) gains 5% intraday, nears resistance

Neogen Chemicals Limited (NSE: NEOGEN) stock moves up 5% intraday to ₹1989.9, approaching resistance at ₹2007 in the Specialty Chemicals sector.

kuldeep yadav tradealone

Published

on

Neogen Chemicals Limited NSE NEOGEN gains 5% nears resistance

Neogen Chemicals Limited (NEOGEN) gained +5% intraday to near resistance at ₹2007. The stock is testing the 6-month resistance trendline but has not cleared it, despite today’s upward move. Neogen operates in the specialty chemicals segment of the basic materials sector, focusing on high-value chemicals and intermediates. Today’s move appears to be driven by technical factors rather than sector momentum, as there is no accompanying news or filing from the company.

Technical setup — trendlines & DMA

Currently, NEOGEN is approaching its 6-month resistance trendline, which stands at ₹2006.76, just 0.85% above today’s price. The stock has broken below the 6-month support trendline, which ends at ₹2014.72, indicating some weakness. However, the 50-day moving average (DMA) of ₹1778.2 is above the 200-DMA of ₹1421.2, signaling a bullish trend. NEOGEN is trading in the upper third of its 52-week range, suggesting that a significant portion of its potential upside may already be priced in.

6M Trendline — Intraday Snapshot
APPROACHING RESISTANCE₹1,200₹1,400₹1,600₹1,800₹2,0001 Apr4 May1 Jun30 Jun

Snapshot: ₹1,989.90 on 2026-06-30 (chart frozen at publication)

Fundamentals & business context

With a PE ratio of 173.2 and profit margins at 3.3%, NEOGEN’s valuation appears stretched relative to its current earnings, especially given its revenue CAGR of 9.3% over the past five years. The company’s institutional ownership of 21.4% suggests that while some smart money is invested, the overall fundamental picture is mixed. There is no new NSE catalyst today driving the move, reinforcing the technical nature of today’s price action.

NEOGEN
Holdings Analysis
Key strengths & risk signals
69
Overall
56
Fundamental
82
Technical
Risks (1)
Cannot calculate PEG - insufficient growth data.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (2197.1) is above 200-day average (1693.0) - positive signal.
EXCELLENT YEAR! Stock gained 58.9% in the last year.
STRONG! Trading at 93.3% of 52W range - near yearly highs.

Algorithmic scorecard

NEOGEN’s algorithmic scorecard reflects a technically strong but fundamentally weak profile. The strongest technical signals include the bullish trend indicated by the 50-DMA being above the 200-DMA and the bullish sentiment over the last 30 days, with 20 up days versus 8 down days. On the fundamental side, the consistent revenue growth every year and the acceptable debt levels (D/E of 0.76) are positives. However, the declining profit CAGR of -16.8% and the negligible dividend yield of 0.05% are significant risks that investors should consider.

Fundamental & Technical AnalysisNSE: NEOGEN
69Overall
56Fundamental
82Technical
Growth Quality10 / 30
Revenue CAGR: 8.7% (MODERATE, 8/15). Profit CAGR: -16.8% (DECLINING, 2/15).
Profit Margin2 / 10
LOW MARGIN! 3.8% profit margin - thin profits.
PEG Valuation1 / 10
Cannot calculate PEG - insufficient growth data.
Dividend Yield3 / 10
NEGLIGIBLE DIVIDEND! 0.04% yield - little to no income.
Debt / Equity10 / 10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding20 / 20
VERY LESS PUBLIC HOLDING! 15.32% public ownership - strong promoter/institutional control.
Stability10 / 10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Moving Averages12 / 10
BULLISH TREND! 50-day average (2197.1) is above 200-day average (1693.0) - positive signal.
Price Position8 / 10
STRONG POSITION! Current price (2396.3) is above both moving averages.
Trend Pattern14 / 20
Current trend: CONSOLIDATING UP
52W Performance10 / 10
EXCELLENT YEAR! Stock gained 58.9% in the last year.
Volume Sentiment20 / 30
BULLISH SENTIMENT! In last 30 days: 18 up days, 12 down days. Avg volume on up days: 221,410 vs down days: 191,693. Ratio: 1.16x
RSI3 / 5
NEUTRAL! RSI at 58.9 - balanced momentum.
52W Range5 / 5
STRONG! Trading at 93.3% of 52W range - near yearly highs.
Momentum5 / 5
STRONG MOMENTUM! Price has grown across all timeframes - up 1.6% (1 week), 8.4% (1 month), 18.3% (3 months). Momentum is accelerating.
Beta / Volatility5 / 5
LOW VOLATILITY! Beta of 0.70 - stable stock, less market risk.

Company outlook

Management provided forward guidance indicating sequential revenue growth in the battery chemicals business, with the majority of sales expected in the second half of the year. For FY27, standalone revenue is guided to be in the range of INR 875 to INR 950 crore, excluding battery chemicals revenue. The tentative target for FY28 revenue is around INR 1,100 crore plus, with potential for additional investment in areas like organolithium, semiconductor, flavor fragrance, or CSM needs. Expected consolidated revenue by FY29 is projected to be in the range of INR 3,700 to INR 4,200 crore. Key plans include the completion of the Dahej Phase 1 project by February 2027 and Pakhajan Phase 2 by March 2027, along with a strategic partnership with Japan’s Morita, involving an equity contribution of $20 million towards the joint venture expected during H1FY27. Additionally, the company plans capacity expansions and technology integrations, including the addition of 500 metric tons of intermediate salt capacity at Dahej.

Get all details on NEOGEN — P&L, peers, shareholding and more on TradeAlone.

ANURAS

Anupam Rasayan India Limited Completes Acquisition of Bliss GVS Pharma, Marks Third Strategic Step

Anupam Rasayan India Limited (ANURAS) completes acquisition of Bliss GVS Pharma, marking third strategic step towards building an integrated global pharma pl.

Shruti singh - TradeAlone

Published

on

Anupam Rasayan India Limited Anuras Acquisition Bliss GVS Pharma

Anupam Rasayan India Limited (BSE: 543275, NSE: ANURAS), one of India’s leading custom synthesis and specialty chemical companies, has concluded the acquisition of a 48.2% controlling stake in Bliss GVS Pharma Limited at ₹299 per share, marking its third strategic inorganic transaction and expanding its presence into finished dosage formulations.

Strategic Milestone

The acquisition, undertaken through Mates Visa Consultancy, a wholly owned subsidiary of Anupam Rasayan, follows the definitive agreement signed on May 23, 2026, and the subsequent completion of the mandatory open offer process. With the acquisition now finalized, Bliss GVS Pharma becomes an integral part of Anupam Rasayan’s expanding portfolio of businesses across specialty chemicals and pharmaceuticals.

Financial and Operational Synergy

The transaction has been funded through a combination of a ₹300 crore term loan and approximately ₹1,450 crore raised through non-controlling, non-voting instruments from a group of financial investors led by Bain Capital and including Trust Group and Investec. The financing structure enables Anupam Rasayan to fund the acquisition while preserving balance-sheet capacity for future growth and expansion.

Future Growth Prospects

On the acquisition, Mr. Anand Desai, Managing Director of Anupam Rasayan India Ltd., said, “We are pleased to announce the successful completion of the acquisition of Bliss GVS Pharma. This transaction marks an important milestone in our long-term strategy to build a diversified, integrated and innovation-led global pharmaceutical platform. The acquisition strengthens our presence in finished pharmaceutical formulations and complements Anupam Rasayan’s expertise in key starting materials, intermediates and specialty chemicals.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Anupam Rasayan India Limited

Anupam Rasayan India Limited belongs to the › sector. Here’s a quick read on where the business and the stock stand today.

ANURAS
Basic Materials › Specialty Chemicals
CONSOLIDATING DOWN
48
Fundamental
38
Technical
43
Overall

1W +2.27%
1M -5.82%
3M -6.11%
P/E: 77.2 Cap: Mid
AI-Powered Analysis • TradeAlone
Download the App for in-depth analysis of this stock

Anupam moves sideways over three months, with neither buyers nor sellers taking control. Thin margins at 6.9% leave limited room for error — any demand softness or cost spike hits the bottom line hard. No meaningful dividend — total return is entirely dependent on capital appreciation. Sellers drive 1.8x the volume of buyers. Furthermore, they controlled 17 of recent sessions versus 13 for buyers — a clear distribution signal. Revenue grows at 14.1% yet the PEG reaches 99.00 — expensive for that growth. Furthermore, the stock drops 6.1% in three months. Neither value nor momentum supports this setup. It needs an earnings beat or a price reset first. Check Fundamentals of Anupam Rasayan India Limited.

Continue Reading

Aluminum

National Aluminium Company Limited (nationalum) Announces Record Dividend Payment for FY 2025-26

National Aluminium Company Limited (NATIONALUM) pays ₹1,083.06 crore dividend to Government of India for FY 2025-26, marking highest-ever payout.

Pranab Tyagi at TradeAlone

Published

on

National Aluminium Company Limited Nationalum FY 2026 Dividend

National Aluminium Company Limited (NATIONALUM) has made headlines today by announcing a record dividend payment of ₹1,083.06 crore to the Government of India for FY 2025-26. This marks the highest-ever dividend paid by the company, reflecting its robust financial performance for the year. The dividend cheque was handed over to Shri G. Kishan Reddy, Hon’ble Union Minister of Coal & Mines, Government of India, during an Investor Roadshow on Angul Aluminium Park held in Kolkata today.

Record-Breaking Dividend

The total dividend paid by NATIONALUM for FY 2025-26 amounts to ₹2,112.12 crore, which includes three interim dividends and a final dividend. This significant payout underscores the company’s commitment to returning value to its shareholders and the government. The robust performance in FY 2025-26 saw a Profit After Tax (PAT) of ₹5,815.76 crore, highlighting the company’s strong financial health and operational efficiency.

Strategic Investment Roadshow

The announcement came during an Investor Roadshow organized by NATIONALUM in association with Odisha Industrial Infrastructure Development Corporation (IDCO) at Angul Aluminium Park in Kolkata. The event aimed to showcase investment opportunities in downstream and value-added aluminium manufacturing. Shri Jagdish Arora, Director (P&T), NATIONALUM, welcomed the attendees and emphasized the investor-friendly ecosystem that supports employment generation and industrial growth.

As a result, the Angul Aluminium Park is poised to become a pivotal platform for establishing and expanding aluminium-based manufacturing operations, fostering innovation, and contributing to India’s vision of building a self-reliant and developed nation.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of National Aluminium Company Limited

National Aluminium Company Limited belongs to the › sector. Here’s a quick read on where the business and the stock stand today.

NATIONALUM
Basic Materials › Aluminum
CONSOLIDATING UP
82
Fundamental
62
Technical
72
Overall

1W -0.99%
1M -11.63%
3M +2.77%
P/E: 9.5 Cap: Large
AI-Powered Analysis • TradeAlone
Download the App for in-depth analysis of this stock

National posts a 2.8% three-month gain, but softens in the last few weeks. The PEG of 0.16 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Industry-leading margins of 34.9% reflect exceptional pricing power and operational efficiency. The stock gives back 11.6% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Revenue grows at 7.8% and profits at 59.3%. The business is in good shape. Moreover, a stock that does not move despite strong fundamentals often offers better value than one already priced for perfection. Check Fundamentals of National Aluminium Company Limited.

Continue Reading

Basic Materials

Ellenbarrie Industrial Gases Limited Secures ₹481 Crore Air Separation Unit Contract

Ellenbarrie Industrial Gases Limited secures a ₹481 crore contract for a 1200 TPD Air Separation Unit from BHEL for its Coal to Ammonium Nitrate project.

Shruti singh - TradeAlone

Published

on

Ellenbarrie Industrial Gases Limited ELLEN Q4 FY26 Contract

Ellenbarrie Industrial Gases Limited (ELLEN) today announced securing a ₹481 crore contract for a 1200 TPD cryogenic Air Separation Unit (ASU) from Bharat Heavy Electricals Ltd. (BHEL) for its Coal to Ammonium Nitrate (2000TPD) project. This marks a significant milestone for ELLEN as it enters one of India’s largest long-term industrial gas opportunities under the National Coal Gasification Mission. The contract includes design, engineering, supply, erection, testing, pre-commissioning, commissioning, trial runs operation, operator training, demonstration of performance guarantees, supply of spares, and handing over, all on a turnkey basis. The project will be executed over eight quarters and is expected to be commissioned in FY29.

Strategic Project Under National Coal Gasification Mission

This contract is part of India’s broader push towards coal gasification, a strategic national initiative aimed at reducing import dependence while creating domestic production capacity for chemicals, fertilisers, and clean industrial feedstocks. The Government of India has outlined an ambitious vision of gasifying 100 million tonnes of coal annually by 2030, with coal gasification expected to support domestic production of ammonia, urea, methanol, hydrogen, and other downstream chemicals.

Significant Milestone for ELLEN

Commenting on the development, Varun Agarwal, Joint Managing Director of ELLEN, said: ‘This order represents an important strategic milestone for ELLEN as we strengthen our participation in India’s emerging coal gasification ecosystem. While this is a Build and Transfer project, it recognises our capability to deliver large-scale cryogenic Air Separation Units for complex industrial applications. As India’s coal gasification programme gathers momentum over the coming years, we believe our engineering expertise, execution track record, and deep experience in industrial gases position us well to participate in this long-term growth opportunity.’ This contract will be the largest plant built by ELLEN till date and takes the company into an exclusive list of companies having the capability of building plants of more than 1000 TPD.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Ellenbarrie Industrial Gases Limited

Ellenbarrie Industrial Gases Limited belongs to the › sector. Here’s a quick read on where the business and the stock stand today.

ELLEN
Basic Materials › Chemicals
—
84
Fundamental
72
Technical
79
Overall

1W -3.86%
1M +12.27%
3M +35.57%
P/E: 41.8 Cap: Mid
AI-Powered Analysis • TradeAlone
Download the App for in-depth analysis of this stock

Ellenbarrie rises 35.6% over three months, with buying pressure holding steady. The PEG of 0.76 signals undervaluation relative to growth. It is a potential re-rating candidate. Industry-leading margins of 33.8% reflect exceptional pricing power and operational efficiency. Buyers show up with 2.2x the volume of sellers. Moreover, they dominated on 17 of recent sessions versus 13 for sellers — a healthy accumulation pattern. Both the business and the stock move in the right direction. Revenue grows at 16.9%, profits at 54.8%, and the PEG sits at 0.76 — below its growth rate. That combination is rare. Check Fundamentals of Ellenbarrie Industrial Gases Limited.

Continue Reading

Trending

Exit mobile version